Neurocentrx Pharma Ltd.

Developer of oral delivery medicines designed to treat patients with neurological conditions. The company's medicines are oral ketamine formulations that treat central nervous system conditions and cancer-related pain, enabling patients to alleviate severe and chronic neuropathic pain conditions.